CRISPR Therapeutics AG
做多

CRSP – Biotech Breakout After Insider Accumulation | Seed System

196
CRSP just cleared its Darvas Box top with momentum, volume, and trend all aligning.

Seed System confirmation:

Darvas Box breakout at $56–58

Massive volume surge following insider/institutional buying (ARK, UBS, T. Rowe)

EMA stack bullish (9 > 21 > 50)

VWMA trending up, price riding the band

MACD bullish cross, RSI moving through 70

Setup:

Entry Zone: $60.00–62.00 (watch for pullback)

Stop Loss: $58.00

Target 1: $70.00

Target 2: $80.00+

Catalyst: Positive CTX310 gene therapy results (LDL & triglyceride drops up to 80%), and biotech sector strength. RS Rating now 85 — breakout quality.

Expecting a retest of the breakout before continuation. Strong long setup if biotech sector holds.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。